|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar
|
|
2
|
Raoul JL, Sangro B, Forner A, Mazzaferro
V, Piscaglia F, Bolondi L and Lencioni R: Evolving strategies for
the management of intermediate-stage hepatocellular carcinoma:
Available evidence and expert opinion on the use of transarterial
chemoembolization. Cancer Treat Rev. 37:212–220. 2011. View Article : Google Scholar
|
|
3
|
Aravalli RN, Steer CJ and Cressman EN:
Molecular mechanisms of hepatocellular carcinoma. Hepatology.
48:2047–2063. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gramantieri L, Ferracin M, Fornari F,
Veronese A, Sabbioni S, Liu CG, Calin GA, Giovannini C, Ferrazzi E,
Grazi GL, et al: Cyclin G1 is a target of miR-122a, a microRNA
frequently down-regulated in human hepatocellular carcinoma. Cancer
Res. 67:6092–6099. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hou J, Lin L, Zhou W, Wang Z, Ding G, Dong
Q, Qin L, Wu X, Zheng Y, Yang Y, et al: Identification of miRNomes
in human liver and hepatocellular carcinoma reveals miR-199a/b-3p
as therapeutic target for hepatocellular carcinoma. Cancer Cell.
19:232–243. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jiang J, Gusev Y, Aderca I, Mettler TA,
Nagorney DM, Brackett DJ, Roberts LR and Schmittgen TD: Association
of MicroRNA expression in hepatocellular carcinomas with hepatitis
infection, cirrhosis, and patient survival. Clin Cancer Res.
14:419–427. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Murakami Y, Yasuda T, Saigo K, Urashima T,
Toyoda H, Okanoue T and Shimotohno K: Comprehensive analysis of
microRNA expression patterns in hepatocellular carcinoma and
non-tumorous tissues. Oncogene. 25:2537–2545. 2006. View Article : Google Scholar
|
|
9
|
Fornari F, Milazzo M, Chieco P, Negrini M,
Calin GA, Grazi GL, Pollutri D, Croce CM, Bolondi L and Gramantieri
L: MiR-199a-3p regulates mTOR and c-Met to influence the
doxo-rubicin sensitivity of human hepatocarcinoma cells. Cancer
Res. 70:5184–5193. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim S, Lee UJ, Kim MN, Lee EJ, Kim JY, Lee
MY, Choung S, Kim YJ and Choi YC: MicroRNA miR-199a*
regulates the MET proto-oncogene and the downstream extracellular
signal-regulated kinase 2 (ERK2). J Biol Chem. 283:18158–18166.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Henry JC, Park JK, Jiang J, Kim JH,
Nagorney DM, Roberts LR, Banerjee S and Schmittgen TD: miR-199a-3p
targets CD44 and reduces proliferation of CD44 positive
hepatocellular carcinoma cell lines. Biochem Biophys Res Commun.
403:120–125. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ke AW, Shi GM, Zhou J, Wu FZ, Ding ZB, Hu
MY, Xu Y, Song ZJ, Wang ZJ, Wu JC, et al: Role of overexpression of
CD151 and/or c-Met in predicting prognosis of hepatocellular
carcinoma. Hepatology. 49:491–503. 2009. View Article : Google Scholar
|
|
13
|
Shi GM, Ke AW, Zhou J, Wang XY, Xu Y, Ding
ZB, Devbhandari RP, Huang XY, Qiu SJ, Shi YH, et al: CD151
modulates expression of matrix metalloproteinase 9 and promotes
neoangiogenesis and progression of hepatocellular carcinoma.
Hepatology. 52:183–196. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ke AW, Shi GM, Zhou J, Huang XY, Shi YH,
Ding ZB, Wang XY, Devbhandari RP and Fan J: CD151 amplifies
signaling by integrin alpha6beta1 to PI3K and induces the
epithelial-mesenchymal transition in HCC cells. Gastroenterology.
140:1629–1641. e152011. View Article : Google Scholar
|
|
15
|
Klosek SK, Nakashiro K, Hara S, Shintani
S, Hasegawa H and Hamakawa H: CD151 forms a functional complex with
c-Met in human salivary gland cancer cells. Biochem Biophys Res
Commun. 336:408–416. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Arora H, Qureshi R and Park WY: miR-506
regulates epithelial mesenchymal transition in breast cancer cell
lines. PLoS One. 8:e642732013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Han ZB, Yang Z, Chi Y, Zhang L, Wang Y, Ji
Y, Wang J, Zhao H and Han ZC: MicroRNA-124 suppresses breast cancer
cell growth and motility by targeting CD151. Cell Physiol Biochem.
31:823–832. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang X, Yu H, Lu X, Zhang P, Wang M and Hu
Y: MiR-22 suppresses the proliferation and invasion of gastric
cancer cells by inhibiting CD151. Biochem Biophys Res Commun.
445:175–179. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tirmenstein MA, Nicholls-Grzemski FA,
Schmittgen TD, Zakrajsek BA and Fariss MW: Characterization of
nitric oxide production following isolation of rat hepatocytes.
Toxicol Sci. 53:56–62. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee
DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, et al:
Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic
Acids Res. 33:e1792005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gebäck T, Schulz MM, Koumoutsakos P and
Detmar M: TScratch: A novel and simple software tool for automated
analysis of monolayer wound healing assays. Biotechniques.
46:265–274. 2009.PubMed/NCBI
|
|
22
|
Duan Q, Wang X, Gong W, Ni L, Chen C, He
X, Chen F, Yang L, Wang P and Wang DW: ER stress negatively
modulates the expression of the miR-199a/214 cluster to regulates
tumor survival and progression in human hepatocellular cancer. PLoS
One. 7:e315182012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shi KQ, Lin Z, Chen XJ, Song M, Wang YQ,
Cai YJ, Yang NB, Zheng MH, Dong JZ, Zhang L, et al: Hepatocellular
carcinoma associated microRNA expression signature: Integrated
bioinformatics analysis, experimental validation and clinical
significance. Oncotarget. 6:25093–25108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sadej R, Grudowska A, Turczyk L, Kordek R
and Romanska HM: CD151 in cancer progression and metastasis: A
complex scenario. Lab Invest. 94:41–51. 2014. View Article : Google Scholar
|
|
25
|
Johnson JL, Winterwood N, DeMali KA and
Stipp CS: Tetraspanin CD151 regulates RhoA activation and the
dynamic stability of carcinoma cell-cell contacts. J Cell Sci.
122:2263–2273. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
DeLong RK, Nolting A, Fisher M, Chen Q,
Wickstrom E, Kligshteyn M, Demirdji S, Caruthers M and Juliano RL:
Comparative pharmacokinetics, tissue distribution, and tumor
accumulation of phosphorothioate, phosphorodithioate, and
methylphosphonate oligonucleotides in nude mice. Antisense Nucleic
Acid Drug Dev. 7:71–77. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Murakami Y, Aly HH, Tajima A, Inoue I and
Shimotohno K: Regulation of the hepatitis C virus genome
replication by miR-199a. J Hepatol. 50:453–460. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang GL, Li YX, Zheng SQ, Liu M, Li X and
Tang H: Suppression of hepatitis B virus replication by
microRNA-199a-3p and microRNA-210. Antiviral Res. 88:169–175. 2010.
View Article : Google Scholar : PubMed/NCBI
|
